2022 News

• 05.10.2022
  Press Release

  Santen Received the Approval of Verkazia (Ciclosporin Eye Drops (III)), Providing New Solutions for Severe Vernal Keratoconjunctivitis in China

• 05.02.2022
  Press Release

  Santen's Verkazia (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States

• 02.28.2022
  Press Release

  Santen Receives Marketing Approval in Japan for "PRESERFLO MicroShunt Glaucoma Drainage System Core Kit" to Treat Glaucoma

• 02.22.2022
  Press Release

  Reinventing of Our Leadership Team to Shape the Future of Santen

• 02.10.2022
  Press Release

  Santen certified as Digital Transformation Business Operator by Ministry of Economy, Trade and Industry

News Archive